1987
DOI: 10.1016/0300-483x(87)90015-1
|View full text |Cite
|
Sign up to set email alerts
|

Monoclonal antibodies for dioxin: Antibody characterization and assay development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
63
0

Year Published

1988
1988
2013
2013

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 57 publications
(67 citation statements)
references
References 22 publications
4
63
0
Order By: Relevance
“…The assay was performed with a solid-phase RIA configuration. Other immunoassays using monoclonal antibodies were developed in the 1980s by Stanker et al [141,142] that were applied to detect dioxins in soils [143] and for rapid screening of dioxins and furans [144,145,146,147]. These ELISAs had a sensitivity similar to the RIA (an IC 50 value about 200 pg TCDD well -1 ).…”
Section: Immunochemical Techniques For Pcdfs and Pcddsmentioning
confidence: 98%
“…The assay was performed with a solid-phase RIA configuration. Other immunoassays using monoclonal antibodies were developed in the 1980s by Stanker et al [141,142] that were applied to detect dioxins in soils [143] and for rapid screening of dioxins and furans [144,145,146,147]. These ELISAs had a sensitivity similar to the RIA (an IC 50 value about 200 pg TCDD well -1 ).…”
Section: Immunochemical Techniques For Pcdfs and Pcddsmentioning
confidence: 98%
“…The development of immunoassays for the PCDDs is complicated by their lipophilic properties, required method sensitivity, and the complex nature of environmental samples. Due to these difficulties, only a few studies have been reported in the development of antibodies and ELISA methods for PCDDs with mixed results (Stanker et al, 1987;Sanborn et al, 1998;Sugawara et al, 1998Sugawara et al, , 2002Harrison and Carlson, 1999;Shan et al, 2001;SW846 Method 4025, 2002;Okuyama et al, 2004;Lo et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…A number of methods have been established for dioxins and related compounds, since routine monitoring of these compounds is difficult, time consuming and expensive; thus, screening methods that offer improvements in speed, sample throughput and cost are particularly desirable. Therefore, the early immunoassays for environmental contaminants include several dioxin assays [24]. Harrison et al [25] developed immunoassays against dioxin and related compounds which are now commercially available and which are based on the DD3 monoclonal antibody.…”
Section: Immunoassaysmentioning
confidence: 99%